Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

Intralesional therapy for keratoacanthoma is effective and has fewer side effects than systemic treatments.

Dermocosmetics help manage skin issues in cancer patients, improving outcomes and reducing treatment interruptions.

Proper skin toxicity management in chemotherapy is key to continuing treatment and keeping patient quality of life high.

New targeted cancer drugs can cause skin side effects, and managing them requires patient education and timely care.

Acne is a common skin condition that can be influenced by diet, lifestyle, and hormones, and requires a treatment approach that includes psychological considerations.

The Wnt signaling pathway is not a major factor in the development of keratoacanthoma, a type of skin tumor.

Men with a certain type of hair loss often use facial moisturizers, and a specific antibiotic treatment may help another hair condition.

Experts created guidelines to better diagnose and treat uncommon fungal skin infections.

Bio-based materials like hydrogels show promise in treating skin cancer with fewer side effects, but more research is needed.

Actinic keratosis is a sun-induced skin condition that can potentially turn into skin cancer and requires treatment to prevent malignancy.

Chemotherapy often causes hair loss in cancer patients, affecting their mental health, but scalp cooling can help prevent it.

Histopathological examination is crucial to avoid misdiagnosis and ensure proper treatment for skin lesions.

A group has developed therapies that show promise for treating cancer and various other conditions.

Minoxidil can stop the growth of ovarian cancer cells without harming the heart.

Hair graying is influenced by factors like nerves, fat cells, and immune cells, not just hair follicles.

Sorafenib and Platycladus orientalis leaf extract together effectively suppress cervical cancer cell growth.

Dutasteride and minoxidil mesotherapy effectively treats hair loss with minimal side effects.

People with allergies or high eosinophil levels have a higher chance of severe hair loss from alopecia areata, and sudden hair loss can indicate chronic graft-versus-host disease.

Regular follow-up visits, especially with dermatologists, can lower death rates for melanoma patients, with socioeconomic factors also affecting outcomes.

Melanoma survival rates vary by state and are better where incomes are higher, more people have health insurance and education, and there are more dermatologists.

A new cosmetic cream reduced facial redness and skin temperature after 4 weeks of use.

Both atopy and eosinophilia are linked to more severe hair loss in people with alopecia areata.

The study found that severe alopecia areata affects any age, treatments often give temporary results, and some factors predict worse outcomes.

People with certain allergic conditions or higher white blood cell counts have more severe hair loss, and treating hair and nail side effects early in melanoma therapy can improve quality of life.

The paper concludes that understanding melanocyte development can help in insights into skin diseases and melanoma diversity.

Finasteride and minoxidil are effective for hair loss, but continued research is needed for better treatments.

Eph receptors and ephrins may be promising targets for treating diseases, but more understanding is needed for effective and safe therapies.

Cancer can hijack the body's cell repair system to promote tumor growth, and targeting this process may improve cancer treatments.

Fibroblasts can be turned into melanocytes for potential skin treatments.